Move over em-dash, there’s a new AI giveaway. It’s hard to deny that AI is everywhere these days, and it’s no surprise that it’s making its way into classrooms. Since sneaky students are figuring out ...

For the first time, Japan has granted approval for medical treatments derived from reprogrammed human cells, offering new hope for patients with severe conditions. This groundbreaking move, marking ...

If there’s one universal experience with AI-powered code development tools, it’s how they feel like magic until they don’t. One moment, you’re watching an AI agent slurp up your codebase and deliver a ...

Children conceived through medically assisted reproduction (MAR) have higher out-of-hospital healthcare utilization than naturally conceived children, with significantly increased costs at ages 2-3 ...

Source: Bioscience Image Library by Fayette Reynolds/Unsplash Anyone living with schizophrenia understands the true limitations of current treatment options. Antipsychotics remain the single leading ...

DULUTH, Ga., Feb. 19, 2026 /PRNewswire/ -- Boehringer Ingelheim, a global leader in animal health, today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use ...

INDIANAPOLIS (Reuters) — U.S. drugmaker Eli Lilly and Company signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the Germany-based startup said on Wednesday, to develop and ...

Manual extraction of treatment outcomes from unstructured oncology clinical notes is a significant challenge for real-world evidence (RWE) generation. This study aimed to develop and evaluate a robust ...

ROANOKE, Va. (WDBJ) - January is Substance Use Treatment Awareness Month as declared by The Substance Abuse and Mental Health Services Administration (SAMHSA). Blue Ridge Behavioral Healthcare works ...

UW-Madison researchers have found potential new treatments for a rare pediatric brain cancer each year that has a median survival time of less than a year. The research involved thousands of fruit ...

For decades, asset protection planning focused on lawsuits and creditor exposure. While those risks still matter, a more subtle threat now dominates: visibility. In a world of data aggregation, online ...

An unlikely, decades-old drug is gaining traction as a promising off-label treatment for fibromyalgia, driven by a handful of studies and a growing number of anecdotal reports. Low-dose naltrexone ...